SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ® APCs and Effective CD8 T Cell Activation

ESMO Immuno-Oncology and Technology Article Details Importance of Intracellular Delivery to Drive Effective MHC-I Mediated Activation of CD8 T Cells Paper Highlights Preclinical SQZ® APC Combination Data with PD-1 IL2v and Manufacturing Benefits of the Cell Squeeze® Technology WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for … [Read more…]

Pacific Life Updates Underwriting Guidelines to Expand Life Insurance Options to Individuals Living With HIV

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Pacific Life has expanded its offering of life insurance coverage to eligible individuals living with human immunodeficiency virus (HIV). “In keeping with our progressive approach to underwriting, we are leveraging the latest medical advancements in therapeutics for HIV in order to offer coverage to individuals living with this chronic condition,” said Dawn … [Read more…]

Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS

 Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment   IDSMC Did Not Identify Any Safety Concerns Phase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023 Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDT SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), … [Read more…]

Cardiac Insight Comments on CMS Plans to Establish Nationwide Payment for Long-Term ECG Monitoring in 2023

U.S. based cardiac arrhythmia diagnostic medical device system innovator supports CMS Proposed National Payment Framework for Long-Term ECG Monitoring BELLEVUE, Wash.–(BUSINESS WIRE)–#AFib—Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements impacting its served markets. These … [Read more…]

Results from a Double-blind Randomized Controlled Trial of Scallop-derived Plasmalogens Published in Frontiers in Cell and Developmental Biology

FUKUOKA, Japan–(BUSINESS WIRE)–The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration. Plasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are … [Read more…]

The Worldwide Wearable Injectors Industry is Expected to Reach $12.9 Billion by 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Wearable Injectors Market Size, Share & Industry Trends Analysis Report By Therapy, By End User, By Type, By Technology, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Wearable Injectors Market size is expected to reach $12.9 billion by 2028, rising at a market … [Read more…]

New Study Shows Advanced Practice Providers Will Play a Growing Role in Primary Care, Other Specialties Moving Forward

– 74% of healthcare organizations have a strategy to increase APP usage for patients seeking primary care – ALPHARETTA, Ga.–(BUSINESS WIRE)–In a new survey of more than 60 organizations representing over 3,000 Advanced Practice Providers (APPs), Coker Group found that three-fourths of diverse health systems have a strategy in place to increase the use of … [Read more…]

$9.3 Billion Worldwide Parenteral Nutrition Industry to 2027 – Featuring B. Braun Melsungen, Grifols and Pfizer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global parenteral nutrition market reached a value of US$ 6.3 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 9.3 Billion by 2027, exhibiting a CAGR of 6.71% … [Read more…]

Announcing Medxoom Signals™ – Advanced Healthcare Risk Mitigation Solution for Stop-Loss Carriers

ATLANTA–(BUSINESS WIRE)–#Healthcare–Medxoom, the industry leading Health Benefits and Payments platform, today announced the release of Signals™, an advanced digital service enabling automated collection, scoring and reporting of risk signals for health benefits underwriters. “Healthcare Stop-Loss providers are constrained from delivering the best solutions due to the slow, fragmented nature of the legacy Healthcare Claims and … [Read more…]